Synendos Therapeutics

Allschwil, Switzerland

Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.

Sep 2025

Grant

Health Care Medical Therapeutics

Top Investors

HTGF (High-Tech Gruenderfonds)Kurma PartnersYsios CapitalZürcher Kantonal BankVenture Kick

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Synendos Therapeutics

Who are Synendos Therapeutics's investors?

Synendos Therapeutics's investors include HTGF (High-Tech Gruenderfonds), Kurma Partners, Ysios Capital, Zürcher Kantonal Bank, Venture Kick.

Where is Synendos Therapeutics headquartered?

Synendos Therapeutics is headquartered in Allschwil, Switzerland.

What does Synendos Therapeutics do?

Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.

What stage is Synendos Therapeutics at?

Synendos Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 1, 2025.

MLA

"Synendos Therapeutics — Funding & Investors." VCBacked, September 1, 2025, https://www.vcbacked.co/company/synendos-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). Synendos Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/synendos-therapeutics

Wikipedia (cite web)

{{cite web |title=Synendos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/synendos-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 1, 2025.